Medical Cannabis: Clinical Practice

$82.00

Shannon O’Hearn (Editor)
MedReleaf, Markham, Ontario, Canada

Alexia Blake (Editor)
MedReleaf, Markham, Ontario, Canada

Bo Angela Wan (Editor)
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto ON, Canada

Stephanie Chan (Editor)
Odette Cancer Centre, Sunnybrook Health Sciences Centre, CA

Edward Chow, Ph.D. (Editor)
Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada

Joav Merrick, M.D., MMedSci, DMSc, (Editor)
Division of Adolescent Medicine, KY Children’s Hospital, Department of Pediatrics, Lexington, Kentucky, USA
National Institute of Child Health and Human Development, Jerusalem, Israel
Division of Pediatrics, Hadassah Hebrew University Medical Centers, Mt Scopus Campus, Jerusalem, Israel
School of Public Health, Georgia State University, Atlanta, Georgia, USA

Series: Health and Human Development
BISAC: MED014000

Clear

Details

Medical cannabis is emerging as an effective treatment option for the management of a variety of common chronic conditions and symptoms, but a lack of scientific evidence demonstrating its efficacy for treating specific indications is hindering the widespread clinical adoption of medical cannabis. Between January 2015 and December 2016, patients who were prescribed medical cannabis in Canada from a single licensed medical cannabis provider were invited to complete an online survey approximately 15-25 minutes in length that assessed baseline demographics. Patients who completed the baseline survey were subsequently invited to complete follow-up surveys at 4 months and 10 months after the completion of the initial survey. The results are described in this book, and the authors hope the information will further facilitate the use of medical cannabis for the benefit of various populations in need. (Imprint: Nova Biomedical)

Additional information

Binding

,